2-氯-4-(二甲基氨基甲基)-6-甲基苯酚 | 82965-44-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 2-氯-4-(二甲基氨基甲基)-6-甲基苯酚
• 中文别名: N-[3-(4-溴苯基)-1-(4-苯基-1,3-噻唑-2-基)-1H-吡唑-5-基]苯酰胺
• 英文名称: 2-chloro-4-dimethylaminomethyl-6-methylphenol
• 英文别名: 2-chloro-4-(N,N-dimethylaminomethyl)-6-methylphenol；2-chloro-4-dimethylaminomethyl-6-methyl-phenol；3-Chlor-4-hydroxy-5-methyl-N,N-dimethyl-benzylamin；Phenol, 2-chloro-4-(dimethylaminomethyl)-6-methyl-；2-chloro-4-[(dimethylamino)methyl]-6-methylphenol
• CAS: 82965-44-4
• 化学式: C₁₀H₁₄ClNO
• 分子量: 199.68
• InChiKey: GRRSSGXAKVJEDK-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  13
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  23.5
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 海关编码：
  2922299090

反应信息

• 作为反应物：
  描述：

  2-氯-4-(二甲基氨基甲基)-6-甲基苯酚 在 potassium hydroxide 作用下， 以 乙二醇二甲醚 、 乙醚 、 乙醇 、 水 为溶剂， 反应 72.0h， 生成 (3-chloro-4-hydroxy-5-methylphenyl)acetic acid
  参考文献：
  名称：

  Discovery of 2-[3,5-Dichloro-4-(5-isopropyl-6-oxo-1,6-dihydropyridazin-3-yloxy)phenyl]-3,5-dioxo-2,3,4,5-tetrahydro[1,2,4]triazine-6-carbonitrile (MGL-3196), a Highly Selective Thyroid Hormone Receptor β Agonist in Clinical Trials for the Treatment of Dyslipidemia

  摘要：

  The beneficial effects of thyroid hormone (TH) on lipid levels are primarily due to its action at the thyroid hormone receptor beta (THR-beta) in the liver, while adverse effects, including cardiac effects, are mediated by thyroid hormone receptor alpha (THR-alpha). A pyridazinone series has been identified that is significantly more THR-beta selective than earlier analogues. Optimization of this series by the addition of a cyanoazauracil substituent improved both the potency and selectivity and led to MGL-3196 (53), which is 28-fold selective for THR-beta over THR-alpha in a functional assay. Compound 53 showed outstanding safety in a rat heart model and was efficacious in a preclinical model at doses that showed no impact on the central thyroid axis. In reported studies in healthy volunteers, 53 exhibited an excellent safety profile and decreased LDL cholesterol (LDL-C) and triglycerides (TG) at once daily oral doses of 50 mg or higher given for 2 weeks.

  DOI：

  10.1021/jm4019299
• 作为产物：
  描述：

  聚合甲醛 、 二甲胺 、 2-氯-6-甲酚 以 乙醇 、 水 为溶剂， 反应 24.0h， 以66%的产率得到2-氯-4-(二甲基氨基甲基)-6-甲基苯酚
  参考文献：
  名称：

  WO2007/9913

  摘要：

  公开号：

文献信息

• 1-(1,3-Dioxolan-2-ylmethyl)-azoles, their salts and their use
  申请人：Hoechst Aktiengesellschaft

  公开号：US04391805A1

  公开（公告）日：1983-07-05

  1-(1,3-Dioxolan-2-ylmethyl)-azoles of the general formula ##STR1## and their stereoisomers and their salts with physiologically acceptable acids, the preparation of these compounds, pharmaceutical formulations containing the latter and their use against mycoses, protozoa and Gram-positive and Gram-negative bacteria are described.

  描述了一般式为##STR1##的1-(1,3-二氧杂环戊烷-2-基甲基)-唑类化合物及其立体异构体和与生理上可接受的酸盐，这些化合物的制备，含有后者的药物配方以及其用于对抗真菌，原虫和革兰氏阳性和革兰氏阴性细菌的用途。
• THYROID HORMONE ANALOGS
  申请人：Haynes Nancy-Ellen

  公开号：US20090005383A1

  公开（公告）日：2009-01-01

  Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as obesity, hyperlipidemia, hypercholesterolemia and diabetes and other related disorders and diseases, and may be useful for other diseases such as NASH, atherosclerosis, cardiovascular diseases, hypothyroidism, thyroid cancer and other disorders and diseases related thereto.

  本文提供了公式（I）的化合物，以及其药学上可接受的盐，其中取代基如说明书所披露的那样。这些化合物和含有它们的药物组合物对于治疗肥胖症、高脂血症、高胆固醇血症和糖尿病以及其他相关疾病和疾病非常有用，并且可能对于其他疾病，如NASH，动脉粥样硬化，心血管疾病，甲状腺功能减退症，甲状腺癌和其他相关的疾病和疾病也有用。
• Thyroid hormone analogs
  申请人：Haynes Nancy-Ellen

  公开号：US20070032494A1

  公开（公告）日：2007-02-08

  Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as obesity, hyperlipidemia, hypercholesterolemia and diabetes and other related disorders and diseases, and may be useful for other diseases such as NASH, atherosclerosis, cardiovascular diseases, hypothyroidism, thyroid cancer and other disorders and diseases related thereto.

  本文提供的化合物公式(I)及其药学上可接受的盐，其中取代基如规范中所述。这些化合物及其含有的药物组成物，可用于治疗肥胖症、高脂血症、高胆固醇血症、糖尿病和其他相关疾病，也可能对NASH、动脉粥样硬化、心血管疾病、甲状腺功能减退症、甲状腺癌和其他相关疾病有用。
• 1-(1,3-Dioxolan-2-ylmethyl)-azole, ihre Salze, Verfahren zu ihrer Herstellung und ihre Verwendung
  申请人：HOECHST AKTIENGESELLSCHAFT

  公开号：EP0050298A2

  公开（公告）日：1982-04-28

  Es werden 1-(1,3-Dioxolan-2-ylmethyl)-azole der allgemeinen Formel sowie ihre Stereoisomeren und ihre Salze mit physiologisch verträglichen Säuren beschrieben, die Herstellung dieser Verbindungen, sie enthaltende pharmazeutische Zubereitungen und ihre Verwendung gegen Mykosen, Protozoen und grampositive sowie gramnegative Bakterien.

  通式为 1-(1,3-二氧戊环-2-基甲基)-唑 以及它们的立体异构体和它们与生理上相容的酸的盐，描述了这些化合物的制备方法、含有它们的药物制剂以及它们对霉菌、原生动物、革兰氏阳性和革兰氏阴性细菌的作用。
• USRE046024E1
  申请人：——

  公开号：——

  公开（公告）日：——